foxo4 dri sequence The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI FOXO4-DRI Vial 10mg — Stemcode
FOXO4 DRI Vial 10mg Stemcode Peptides The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOXO4 DRI 10mg senescence research 24Peptides FOXO4 DRI Excenen PharmaTech
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



